Alembic Pharma rebounds, up 4% on USFDA nod to Fluorouracil injection
News2023-03-06
182 Views
Shares of Alembic Pharma traded higher on Monday after the company received final approval from USFDA for its Fluorouracil Injection 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial.
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Breaking News: Crown Equity Holdings, Inc. Announces Letter of Intent with Stewart Holdings LLP
